In a letter dated February 23 to the Department of Telecom (DoT) secretary Amit Agrawal, BIF highlighted the legal opinion ...
Adobe might face competition from GenAI applications. Read why investors should look beyond the hurdles this software giant ...
Sogroya® (somapacitan-beco) is a once-weekly treatment option, offering an alternative to once-daily therapy, which may help ...
Neurogene received FDA Breakthrough Therapy Designation for NGN-401 in Rett Syndrome, driving a >25% share price surge. Click ...
Introduction Burnout among healthcare professionals remains a critical public health issue linked to impaired cognition, emotional exhaustion and diminished clinical performance. Structured breathing ...
An analysis of a «trampled» (blocked or stagnant) peace process requires detailed consideration. After all, when the ...
Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of ...
Half-yearly results for the six months ended 30 November 2025 PR Newswire LONDON, United Kingdom, February 27 27 ...
The matter pertains to a direction issued by the central government in November that will ensure app-based communication ...
Broadband India Forum, an industry body that represents major tech firms like Meta, Google, and others, has questioned the legal validity of the government's SIM binding mandate, citing a senior ...
The Indian markets are under pressure, and the Nifty index is down nearly 100 points, falling below the 25,400 mark. The Sensex index is also down 250 points, falling to the 82,000 mark. The Nifty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results